Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2019
As of Sep 30, 2019
Q2 FY2019
As of Jun 30, 2019
Q1 FY2019
As of Mar 31, 2019
Q4 FY2018
As of Dec 31, 2018
Q3 FY2018
As of Sep 30, 2018
Q2 FY2018
As of Jun 30, 2018
Q1 FY2018
As of Mar 31, 2018
Q4 FY2017
As of Dec 31, 2017
Q3 FY2017
As of Sep 30, 2017
Q2 FY2017
As of Jun 30, 2017
Assets
Current assets
Cash and cash equivalents
Inventories
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Intangible assets, net
Goodwill
Other non-current assets
Total assets
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable and accrued expenses
Accrued compensation
Current portion of long-term debt, net of debt issuance costs
Deferred revenue
Related party convertible note - net of debt issuance costs
Current portion of deferred rent
Total current liabilities
Deferred rent, net of current portion
Deferred tax liability
Total liabilities
Stockholders’ equity
Common stock $0.001 par value; 50,000,000 shares authorized, 17,052,340 issued and 16,832,593 outstanding at September 30, 2019 and 50,000,000 shares authorized, 16,639,586 issued and 16,494,838 outstanding at December 31, 2018
Additional paid in capital
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support